2023 / 01

Next Paper
DOI: 10.24075/brsmu.2023.007

ORIGINAL RESEARCH

Main state industrial policy measures for the pharmaceutical industry of the Russian Federation

Gaydin TY1,2, Geller EV2, Rozhnova SA2, Gaydina TA2
About authors

1 Lomonosov Moscow State University, Moscow, Russia

2 Pirogov Russian National Research Medical University, Moscow, Russia

Correspondence should be addressed: Timofey Yu. Gaydin
Ostrovityanova, 1, Moscow, 117997, Russia; ur.usm.noce@nidyag

About paper

Author contribution: Gaydin TY, Geller EV — literature analysis, study conduct, manuscript authoring; Rozhnova SA, Gaydina TA — literature analysis, study planning and conduct, manuscript authoring.

Received: 2023-01-30 Accepted: 2023-02-22 Published online: 2023-02-28
|
  1. Dannye roznichnogo audita farmacevticheskogo rynka RF DSM Group. 2022. [citirovano 2023 Yanvar' 28] Dostupno po ssylke: https://dsm.ru/docs/analytics/Июнь%202022%20Итог.pdf. Russian.
  2. Solodova R. Analitika ot GxP News. 2022. [citirovano 2022 Dekabr' 24]. Dostupno po ssylke: https://gxpnews.net/2022/06/farmotrasl-rossii-na-nachalo-2022-goda/. Russian.
  3. DSM Group. Farmacevticheskij rynok Rossii: Dekabr' 2022 g. 2022. [citirovano 2023 Yanvar' 28]. Dostupno po ssylke: https:// dsm.ru/marketing/free-information/analytic-reports/. Russian.
  4. Oborin MS. Problemy i perspektivy importozameshheniya v farmacevticheskoj otrasli. Vestnik NGIEhI. 2021; 5 (120): 101–10. DOI: 10.24412/2227-9407-2021-5-101-110. Russian.
  5. Kurdin A, Shastitko A. The new industrial policy: a chance for the BRICS countries. BRICS Journal of Economics. 2020; 1 (1): 60–80. DOI: 10.38050/2712-7508-2020-5.
  6. Kalinin A. Postroenie sbalansirovannoj promyshlennoj politiki: voprosy strukturirovaniya celej, zadach, instrumentov. Voprosy ehkonomiki. 2012; (4): 132–146. DOI: 10.32609/0042-87362012-4-132-146. Russian.
  7. Korzh NV, Shkatova KV, Supikov V. N. Sovremennye tendencii razvitiya rossijskogo rynka truda. Izvestiya vysshix uchebnyx zavedenij. Povolzhskij region. Obshhestvennye nauki. 2022; 2 (62): 40–51. Russian.
  8. Postanovlenie Pravitel'stva Rossijskoj Federacii ot 05.04.2022 # 593 «Ob osobennostyax obrashheniya lekarstvennyx sredstv dlya medicinskogo primeneniya pri vozniknovenii defektury ili riska vozniknoveniya defektury v svyazi s vvedeniem v otnoshenii Rossijskoj Federacii ogranichitel'nyx mer ehkonomicheskogo xaraktera». 2023. [citirovano 2023 Mart 02]. Dostupno po ssylke: http://publication.pravo.gov.ru/Document/View/0001202204110030?index=0&rangeSize=1. Russian.
  9. Federal'nyj zakon #323 ot 21.11.2011 «Ob osnovax oxrany zdorov'ya grazhdan v RF». 2023. [citirovano 2023 Mart 02]. Dostupno po ssylke: https://www.zakonrf.info/zakon-o-zdorovyegrazhdan/. Russian.
  10. Pooled Procurement of Drugs in Low and Middle Income Countries. [citirovano 2023 Yanvar' 28]. Dostupno po ssylke: https://www.tse-fr.eu/sites/default/files/TSE/documents/doc/ wp/2019/wp_tse_999.pdf.
  11. Scheckel CJ, Vincent Rajkumar S. Drug importation: limitations of current proposals and opportunities for improvement. Blood Cancer Iournal. 2021; 11 (7): 132. DOI: 10.1038/s41408-02100522-3.
  12. Minssen T, Kesselheim AS, Darrow JJ. An export-only exception to pharmaceutical patents in Europe: should the United States follow suit? Nat Biotechnol. 2019; 37 (1): 21–22. DOI: 10.1038/ nbt.4324.
  13. Gaydin TY, Rozhnova SA. Compulsory licensing in pharmaceutical industry: current state of affairs and prospects. Bulletin of RSMU. 2021;(2):5–10. DOI: 10.24075/brsmu.2021.011.
  14. Schuhmacher A, Gassmann O, McCracken N, Hinder M. Open innovation and external sources of innovation. An opportunity to fuel the R&D pipeline and enhance decision making?. Journal of Translational Medicine. 2018; 16 (1): 119. DOI: 10.1186/s12967018-1499-2.
  15. Sokolova SV, Kareva NN, Ivanov AS. Farmacevticheskij rynok: klasternyj vektor razvitiya. Problemy sovremennoj ehkonomiki. 2017; 4 (64): 173–8. Russian.
  16. Dorozhkina TV, Pilgun YaS. Osobennosti razvitiya Kaluzhskogo farmacevticheskogo klastera v usloviyax vneshnix vyzovov: pandemiya koronavirusa. Ehkonomika i biznes: teoriya i praktika. 2020; 51 (63): 169–72. DOI: 10.24411/2411-04502020-10400. Russian.
  17. Dorozhkina TV, Tatarchenko KR, Kuznecova AA. Nacproekt «Mezhdunarodnaya kooperaciya i ehksport»: smeshhenie akcenta na regional'nyj uroven'. Vestnik obrazovatel'nogo konsorciuma Srednerusskij universitet. Seriya: Ehkonomika i upravlenie. 2022; (20): 16–18. Russian.
  18. Chen J, Xie L. Industrial policy, structural transformation and economic growth: evidence from China. Front Bus. Res China. 2019; 13 (18): https://doi.org/10.1186/s11782-019-0065-y.
  19. Lane N. Manufacturing Revolutions: Industrial Policy and Industrialization in South Korea. 2022. 2023. [citirovano 2023 Mart 02]. Dostupno po ssylke: http://dx.doi.org/10.2139/ssrn.3890311.
  20. Huang Z, Lan Y, Zha X. Research on government subsidy strategies for new drug R&D considering spillover effects. PloS One. 2022; 17 (2): e0262655. DOI: 10.1371/journal.pone.0262655.
  21. Postanovlenie Pravitel'stva Moskvy ot 11.02.2016 N 38-PP «O merax po realizacii promyshlennoj i investicionnoj politiki v gorode Moskve». 2023. [citirovano 2023 Mart 02]. Dostupno po ssylke: https://www.mos.ru/depr/documents/view/269724220/. Russian.